Celgene Corp.

Celgene Corp.

Celgene Corp.

Overview
Date Founded

1986

Type of Company

Public

Employees (Worldwide)

8,852

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Contact Data
Trying to get in touch with decision makers at Celgene Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Executive Vice President & General Counsel

Senior Vice President, Chief Compliance Officer

Chief Medical Officer

Executive Vice President, Head of Business Development & Global Alliances

President, Research & Early Development

President, Global Inflammation & Immunology

President, Global Hematology & Oncology

Executive Vice President & Chief Corporate Strategy Officer

Executive Vice President, Corporate Affairs & Market Access

Board of Directors

Chairman & Chief Executive Officer at Celgene Corp.

Former President & Chief Executive Officer at Health Care Service Corp.

Co-Director of the Wills Vision Research Center at Thomas Jefferson University

Chief Executive Officer Emeritus at City of Hope - California

Executive Chairman at Kaleido Biosciences, Inc.

Director & Vice President at Liberator Medical Supply, Inc.

Chief Executive Officer at Grail, Inc.

Paths to Celgene Corp.
Potential Connections via
Relationship Science
You
Celgene Corp.
Owners & Shareholders
Details Hidden

Renaissance Technologies LLC is an investment management company dedicated to producing superior returns for its clients and employees by adhering to mathematical and statistical methods.

Details Hidden

Founded in 2003 Credit Suisse USA LLC is a broker/dealer headquartered in New York City with offices worldwide. The firm is a subsidiary of Credit Suisse Group AG (NYSE: CS).The Credit Suisse equity research equity group engages in a broad range of activities for investors including sales, trading, financing, prime brokerage and market-making in US and international equity and equity related securities, options, futures, risk management and hedging products. Their activities cover both exchange-traded and over-the-counter traded securities, including American depository receipts, restricted stocks, equity repurchases, block trade executions, program trading executions, equity derivatives and convertible securities.Their fixed-income franchise operates as a single, unified platform that handles all fixed-income cash and derivative products. Products and services range from securitization and liability management transactions to sales and trading and superior research.

Details Hidden

Orbis employs a value-oriented investment approach that seeks to identify equities with prices that are well below the perceived intrinsic value of the company. Although the firm employs a value orientation, they do not limit their investments only to stocks that can be defined as value stocks based on their current financial ratios. Orbis looks for companies with attractive growth prospects and companies that trade at lower prices than their true worth.

Recent Transactions
Details Hidden

Amgen, Inc. purchases Celgene Corp. /OTEZLA Assets from Celgene Corp.

Details Hidden

Bristol-Myers Squibb Company purchases Celgene Corp.

Details Hidden

Celgene Corp. purchases Juno Therapeutics, Inc.

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Celgene Corp.

Investment Advisor

Advised onBristol-Myers Squibb Company purchases Celgene Corp.

Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onCelgene Corp. purchases Juno Therapeutics, Inc.

Legal Advisor

Advised onCelgene Corp. purchases Abraxis BioScience, Inc.

Advisors & Consultants
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Key Stats and Financials As of 2018
Market Capitalization
$76.6B
Total Enterprise Value
$61.3B
Earnings Per Share
$5.51
Revenue
$15.3B
Net Profit
$4.05B
EBITDA
$7.42B
EBITDAMargin
48.53%
Total Debt
$20.3B
Total Equity
$6.16B
Enterprise Value Sales
4.01x
Enterprise Value EBITDAOperating
8.26x
TEVNet Income
15.14x
Debt TEV
0.33x
Three Year Compounded Annual Growth Rate Of Revenue
19.76%
Five Year Compounded Annual Growth Rate Of Revenue
18.72%
Non-Profit Donations & Grants
Political Donations
$1,000
2014
$1,500
2014
$2,500
2014
Investments
Details Hidden

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Details Hidden

VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.

Details Hidden

OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD.

Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Senior Director, Global Regulatory Affairs at Celgene Corp.

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Concert Pharmaceuticals, Inc. Medical Support Services | Lexington, MA

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

GlobeImmune, Inc. Medical Support Services | Louisville, Colorado

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Awards & Honors
Rank #305
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #305
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
Rank #12
2011
Forbes Magazine - The Nifty 50
Sponsored by
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Celgene Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Celgene Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Celgene Corp..